Guaiacol-d7

Guaiacol-d7 is the deuterium labeled Guaiacol[1]. Guaiacol, a phenolic compound, inhibits LPS-stimulated COX-2 expression and NF-κB activation[1]. Anti-inflammatory activity[2].

Product Specifications

CAS Number

[1065473-05-3]

Product Name Alternative

2-Methoxyphenol-d7

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

COX; Endogenous Metabolite; NF-κB

Type

Isotope-Labeled Compounds

Related Pathways

Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Solubility

10 mM in DMSO

Smiles

[2H]C([2H])([2H])OC1=C(C([2H])=C([2H])C([2H])=C1[2H])O

Molecular Formula

C7HD7O2

Molecular Weight

131.18

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Murakami Y, et al. Re-evaluation of cyclooxygenase-2-inhibiting activity of vanillin and Guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res. 2007 Mar-Apr;27 (2) :801-7.